Category: 1-HeadlineNews

Binyamin Netanyahu heralded Israel’s partnership with America as “second to none”, after meeting Donald Trump in Florida to discuss the ceasefire in Gaza.

---

Hosted on Acast. See acast.com/privacy for more information.

Plus: China’s gaming market could continue to grow in 2026. And Louis V. Gerstner Jr., former IBM CEO, dies at 83. Julie Chang hosts.

Learn more about your ad choices. Visit megaphone.fm/adchoices

Plus: Psychiatrists say using AI chatbots might be linked to psychosis. And some audiobooks are outselling hardcovers. Julie Chang hosts.

Learn more about your ad choices. Visit megaphone.fm/adchoices

Nigeria’s government said that American strikes hit two Islamic State-linked camps in north-western Nigeria on Thursday

---

Hosted on Acast. See acast.com/privacy for more information.

Precious metals are set for a sparkling end of the year

---

Hosted on Acast. See acast.com/privacy for more information.

Plus: Nvidia and Coupang shares jump. And analysts say Samsung Electronics and SK Hynix could benefit from DRAM demand. Julie Chang hosts.

Learn more about your ad choices. Visit megaphone.fm/adchoices

Plus: China sanctions U.S. defense companies and executives including Northrop Grumman, Boeing and Palmer Luckey over Taiwan arms sale. And Google will let users change their Gmail address. Julie Chang hosts.

Learn more about your ad choices. Visit megaphone.fm/adchoices

After a $7,500 federal tax credit for electric vehicles purchases expired in September, some consumers are questioning whether the battery-powered cars are really worth their price tags. WSJ reporters Imani Moise and Ryan Felton join us to talk about how automakers—and buyers—are rethinking their EV strategies as the industry landscape shifts. Isabelle Bousquette hosts.

Sign up for the WSJ's free Technology newsletter.

Learn more about your ad choices. Visit megaphone.fm/adchoices

A surprisingly strong GDP report boosted investors' spirits. Plus: American depositary receipts for Novo Nordisk rise after U.S. regulators approved a pill version of weight-loss drug Wegovy. Danny Lewis hosts.

Sign up for the WSJ's free What's News newsletter.

An artificial-intelligence tool assisted in the making of this episode by creating summaries that were based on Wall Street Journal reporting and reviewed and adapted by an editor.

Learn more about your ad choices. Visit megaphone.fm/adchoices